NCT06286592Completed
LUNGevity: Lung Cancer Stigma Community Based Participatory Research
CBPR Intervention to Decrease Lung Cancer Stigma and Health Disparities (LUNGevity Lung Cancer Stigma Reduction)
Source: ClinicalTrials.gov · Last updated 17 Apr 2026
Brief summary (registry, in English)
Lung cancer survival rates are low for intersectional underserved groups. Lung cancer stigma and intersectional stigma related to minoritized group status leads to increased morbidity and mortality and health disparities. Mindfulness interventions have been shown to decrease stigma and the negative impacts of stigma, however, these interventions have never been tested to decrease lung cancer stigma specifically. In this study, the investigators will use Community Based Participatory Research framework and MOST methodology to build and optimize a brief virtual mindfulness intervention to decrease lung cancer stigma, through first building a diverse coalition of lung cancer patients on a participatory action council.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 108 (actual)
- First submitted
- 7 Dec 2023
- Start date
- Jul 2024
- Primary completion date
- Apr 2026
- Lead sponsor
- Rutgers, The State University of New Jersey
- Diseases
- Lung cancer
- NCT number
- NCT06286592
What you commit to
- Study type: Interventional
- Participants enrolled: 108
- From Jul 2024 to the primary completion date, Apr 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Patients who are under the age of 18 and who do not have a history of tobacco use will be excluded from participating in the study.
Other
- Any potential participants who do not meet the above inclusion criteria will be excluded from the study.
- Individuals who cannot read or understand English or who do not have normal to corrected vision and hearing will be excluded from the study.
Who the study is looking for
- Participants must be patients 18 years of age or older with a history of tobacco use to qualify for study inclusion. At least a portion of the participants will also need to be current lung cancer patients. Participants must be able to read and understand English and have normal to corrected vision and hearing.
- For the Community Advisory Board (CAB), participants must have been diagnosed with lung cancer, be at least 18 years of age or older, and self-identify as being part of an underrepresented group identity.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Graduate School of Applied and Professional Psychology Coordinator of this site? Confirm its status | Piscataway | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.